Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
Status:
Completed
Trial end date:
2021-07-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the combination of tremelimumab and durvalumab with
brain radiation therapy can help treat this type of breast cancer that has spread to the
brain.